Effects of epidermal growth factor on glucose metabolism in neonatal rats

Y. Sato, Y. Hiramatsu, T. Kudo

Research output: Contribution to journalArticlepeer-review


Epidermal growth factor (EGF) may play a key role in fetal growth. We have investigated the effects of EGF on glucose metabolism, the main source of energy during the early neonatal period. When compared to control, EGF treatment increased hepatic glycogen, plasma insulin, and the proportion of B cells in the islets of Langerhans, but decreased the concentration of plasma glucagon. Thus, the insulin-to-glucagon molar ratio in plasma was increased in the EGF-treated group. These data suggest that EGF shifts glucose metabolism from catabolism towards anabolism during the early neonatal period by controlling the pancreatic endocrine system. This effect may help the neonate in adapting to the extrauterine environment after birth.

Original languageEnglish
Pages (from-to)26-32
Number of pages7
JournalBiology of the Neonate
Issue number1
Publication statusPublished - Jan 1 1995


  • Epidermal growth factor
  • Glucose metabolism
  • Neonatal growth
  • Pancreas

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental Biology


Dive into the research topics of 'Effects of epidermal growth factor on glucose metabolism in neonatal rats'. Together they form a unique fingerprint.

Cite this